July 20, 2012 — Ticagrelor, a blood-thinning drug approved by the U.S. Food and Drug Administration (FDA) in 2011, should be considered along with older blood thinners clopidogrel and prasugrel for treating patients who are experiencing chest pain or some heart attacks, according to joint updated guidelines issued by the American Heart Association (AHA) Task Force on Practice Guidelines and the American College of Cardiology (ACCF) Foundation.

July 20, 2012 — The online clinical drug resource Drugs.com released first quarter 2012 U.S. prescription sales data for the top 100 drugs. Blood thinners, proton-pump inhibitors, antipsychotics and asthma therapeutic categories continue to remain top sellers.

July 20, 2012 — The ability to see inside the arteries of vascular disease patients in high resolution before and during stenting procedures can offer valuable information. A new study of optical coherence tomography (OCT) in the Journal of Endovascular Therapy confirms the safety and feasibility of this imaging technique in the carotid arteries.

July 20, 2012 — Crux Biomedical announced it has received U.S. Food and Drug Administration (FDA) clearance for its novel inferior vena cava filter (VCF) with bi-directional retrieval.

July 20, 2012 —Acusphere Inc. announced that it had completed the marketing authorization application (MAA) dossier for its lead product candidate, Imagify (perflubutane polymer microspheres) for injectable suspension, and is now starting the process of filing the MAA dossier with the European Medicines Agency (EMA) to support the regulatory review of Imagify in the European Union.

July 20, 2012 — Sony Electronics is announcing the world's first medical-grade monitor, model PVM-2551MD, based on organic light-emitting diode (OLED) technology. The new 25-inch monitor, which recently received U.S. Food and Drug Administration (FDA) 510(k) clearance, is expected to deliver significant benefits for a variety of surgical procedures and combines all the noted advantages of Sony's OLED technology: true-to-life color reproduction, high resolution and virtually no motion blur.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now